share_log

美诺华(603538.SH):阿托伐他汀钙原料药获得欧洲CEP证书

Ningbo Menovo Pharmaceutical (603538.SH): Atorvastatin Calcium Active Pharmaceutical Ingredient Obtains Europe CE Pedigree Certificate

Gelonghui Finance ·  Sep 19, 2024 16:24

Ningbo Menovo Pharmaceutical (603538.SH) announced that the company has received the European CEP certificate (European Pharmacopoeia Applicability Certificate) for atorvastatin calcium (active pharmaceutical ingredient), issued by the European Directorate for the Quality of Medicines (EDQM). Atorvastatin calcium is a statin lipid-lowering drug which mainly acts on the liver, reducing cholesterol synthesis, increasing the synthesis of low-density lipoprotein receptors, lowering blood cholesterol and low-density lipoprotein cholesterol levels, moderately reducing serum triglyceride levels, and increasing blood high-density lipoprotein cholesterol levels.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment